These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 3519914)

  • 1. Persistence of antibody and response to booster dose of Haemophilus influenzae type b polysaccharide diphtheria toxoid conjugate vaccine in infants immunized at 9 to 15 months of age.
    Lepow M; Randolph M; Cimma R; Larsen D; Rogan M; Schumacher J; Lent B; Gaintner S; Samuelson J; Gordon L
    J Pediatr; 1986 Jun; 108(6):882-6. PubMed ID: 3519914
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Persistence of antibody and booster responses to reimmunization with Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children initially immunized at 15 to 24 months of age.
    Berkowitz CD; Ward JI; Chiu CE; Marcy SM; Gordon L; Hendley JO; Meier K; Marchant CD; McVerry P
    Pediatrics; 1990 Mar; 85(3):288-93. PubMed ID: 2304781
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of carrier protein priming on antibody responses to Haemophilus influenzae type b conjugate vaccines in infants.
    Granoff DM; Holmes SJ; Belshe RB; Osterholm MT; McHugh JE; Anderson EL
    JAMA; 1994 Oct; 272(14):1116-21. PubMed ID: 7933324
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Immunogenicity of the Haemophilus influenzae type b capsular polysaccharide conjugate vaccine in children after systemic Haemophilus influenzae type b infections.
    Kaplan SL; Zahradnik JM; Mason EO; Dukes CM
    J Pediatr; 1988 Aug; 113(2):272-7. PubMed ID: 3260943
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Safety and immunogenicity of Haemophilus influenzae type b-polysaccharide diphtheria toxoid conjugate vaccine in infants 9 to 15 months of age.
    Lepow ML; Samuelson JS; Gordon LK
    J Pediatr; 1985 Feb; 106(2):185-9. PubMed ID: 3871477
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Safety, tolerability, and immunogenicity of concurrent administration of Haemophilus influenzae type b conjugate vaccine (meningococcal protein conjugate) with either measles-mumps-rubella vaccine or diphtheria-tetanus-pertussis and oral poliovirus vaccines in 14- to 23-month-old infants.
    Dashefsky B; Wald E; Guerra N; Byers C
    Pediatrics; 1990 Apr; 85(4 Pt 2):682-9. PubMed ID: 2107519
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Immunogenicity of Haemophilus influenzae type b capsular polysaccharide vaccines in 18-month-old infants.
    Hendley JO; Wenzel JG; Ashe KM; Samuelson JS
    Pediatrics; 1987 Sep; 80(3):351-4. PubMed ID: 3306597
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Interchangeability of Haemophilus influenzae type b vaccines in the primary series: evaluation of a two-dose mixed regimen.
    Bewley KM; Schwab JG; Ballanco GA; Daum RS
    Pediatrics; 1996 Nov; 98(5):898-904. PubMed ID: 8909483
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Studies on the combined administration of Haemophilus influenzae type B--diphtheria toxoid conjugate vaccine (PRP-D) and DTP.
    Gordon LK
    Dev Biol Stand; 1986; 65():113-21. PubMed ID: 3549393
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Comparative trial in infants of four conjugate Haemophilus influenzae type b vaccines.
    Decker MD; Edwards KM; Bradley R; Palmer P
    J Pediatr; 1992 Feb; 120(2 Pt 1):184-9. PubMed ID: 1735812
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Antibody levels achieved in infants by course of Haemophilus influenzae type B polysaccharide/diphtheria toxoid conjugate vaccine.
    Eskola J; Käyhty H; Peltola H; Karanko V; Mäkelä PH; Samuelson J; Gordon LK
    Lancet; 1985 May; 1(8439):1184-6. PubMed ID: 2860387
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical trials of the Haemophilus influenzae type b capsular polysaccharide-diphtheria toxoid conjugate vaccine.
    Lepow M
    Pediatr Infect Dis J; 1987 Aug; 6(8):804-7. PubMed ID: 3313246
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reimmunization of children immunized at 18 months of age with Haemophilus influenzae type b vaccine.
    Glode MP; Joffe LS; Brogden R; Kuo J
    J Pediatr; 1988 May; 112(5):703-8. PubMed ID: 3258908
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and immunogenicity of Haemophilus influenzae type b polysaccharide and polysaccharide diphtheria toxoid conjugate vaccines in children 15 to 24 months of age.
    Berkowitz CD; Ward JI; Meier K; Hendley JO; Brunell PA; Barkin RA; Zahradnik JM; Samuelson J; Gordon L
    J Pediatr; 1987 Apr; 110(4):509-14. PubMed ID: 3550021
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Immunogenicity of Haemophilus influenzae type b polysaccharide--diphtheria toxoid conjugate vaccine in adults.
    Granoff DM; Boies EG; Munson RS
    J Pediatr; 1984 Jul; 105(1):22-7. PubMed ID: 6610736
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Limited efficacy of a Haemophilus influenzae type b conjugate vaccine in Alaska Native infants. The Alaska H. influenzae Vaccine Study Group.
    Ward J; Brenneman G; Letson GW; Heyward WL
    N Engl J Med; 1990 Nov; 323(20):1393-401. PubMed ID: 2233906
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and immunogenicity of Haemophilus influenzae type b polysaccharide-diphtheria toxoid conjugate vaccine (PRP-D) in infants.
    Lepow ML; Barkin RM; Berkowitz CD; Brunell PA; James D; Meier K; Ward J; Zahradnik JM; Samuelson J; McVerry PH
    J Infect Dis; 1987 Oct; 156(4):591-6. PubMed ID: 3497990
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Elevated levels of maternal anti-tetanus toxin antibodies do not suppress the immune response to a Haemophilus influenzae type b polyribosylphosphate-tetanus toxoid conjugate vaccine.
    Panpitpat C; Thisyakorn U; Chotpitayasunondh T; Fürer E; Que JU; Hasler T; Cryz SJ
    Bull World Health Organ; 2000; 78(3):364-71. PubMed ID: 10812736
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunogenicity of Haemophilus influenzae type b conjugate vaccines in infant rhesus monkeys.
    Vella PP; Ellis RW
    Pediatr Res; 1991 Jan; 29(1):10-3. PubMed ID: 2000253
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Immunogenicity of four Haemophilus influenzae type b conjugate vaccines in 17- to 19-month-old children.
    Holmes SJ; Murphy TV; Anderson RS; Kaplan SL; Rothstein EP; Gan VN; Granoff DM
    J Pediatr; 1991 Mar; 118(3):364-71. PubMed ID: 1999775
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.